EMPFIELD JAMES R.
Insider CIK 1665430 · XENE SVP, Drug Discovery
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2024-03-11 | 2024-03-12 | 65,000 | — | $0 | 65,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2023-03-10 | 2023-03-14 | 75,000 | — | $0 | 75,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2022-08-12 | 2022-08-16 | 20,000 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2022-08-12 | 2022-08-16 | 45,000 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2022-08-12 | 2022-08-16 | 45,000 | $4.75 | $213.8K | 75,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | F Tax w/h | 2022-08-12 | 2022-08-16 | 7,257 | $38.02 | $275.9K | 67,743 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2022-08-12 | 2022-08-16 | 35,868 | $38.08 | $1.37M | 31,875 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2022-08-12 | 2022-08-16 | 21,875 | $38.68 | $846.1K | 10,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2022-08-12 | 2022-08-16 | 20,000 | $3.10 | $62.0K | 30,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2022-03-10 | 2022-03-14 | 65,000 | — | $0 | 65,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2022-03-07 | 2022-03-08 | 2,500 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2022-03-07 | 2022-03-08 | 40,000 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2022-03-07 | 2022-03-08 | 31,048 | $30.54 | $948.2K | 10,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2022-03-07 | 2022-03-08 | 1,805 | $30.62 | $55.3K | 41,048 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | F Tax w/h | 2022-03-07 | 2022-03-08 | 8,952 | $30.23 | $270.6K | 42,853 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2022-03-07 | 2022-03-08 | 40,000 | $6.76 | $270.4K | 51,805 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | F Tax w/h | 2022-03-07 | 2022-03-08 | 695 | $30.23 | $21.0K | 11,805 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2022-03-07 | 2022-03-08 | 2,500 | $8.40 | $21.0K | 12,500 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2022-03-04 | 2022-03-08 | 25,000 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2022-03-04 | 2022-03-08 | 18,315 | $30.79 | $563.9K | 10,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | F Tax w/h | 2022-03-04 | 2022-03-08 | 6,685 | $31.42 | $210.0K | 28,315 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2022-03-04 | 2022-03-08 | 25,000 | $8.40 | $210.0K | 35,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2021-03-12 | 2021-03-15 | 65,000 | — | $0 | 65,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2020-03-12 | 2020-03-13 | 65,000 | — | $0 | 65,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2019-09-16 | 2019-09-18 | 40,000 | — | $0 | 40,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2018-03-12 | 2018-03-13 | 45,000 | — | $0 | 45,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2017-10-23 | 2017-10-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | P Buy | 2017-08-15 | 2017-08-17 | 10,000 | $2.48 | $24.8K | 10,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2017-03-13 | 2017-03-14 | 27,500 | — | $0 | 27,500 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2016-02-08 | 2016-02-09 | 40,000 | — | $0 | 40,000 | SEC↗ |